US Map / Wisconsin
State WI

Clinical Trials in Wisconsin

Wisconsin is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Wisconsin and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 167 actively recruiting studies with Wisconsin sites out of 167 registered in total. The busiest research areas in Wisconsin are Breast Cancer, Prostate Cancer, Colorectal Cancer. Leading sponsors running trials in the state include University of Wisconsin, Madison, Medical College of Wisconsin, National Cancer Institute (NCI). By stage, Wisconsin trials break down as Phase 1 (34), Phase 2 (47), Phase 3 (43), Phase 4 (7).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
167
Recruiting Now
167
← Back to US Map
Top Conditions in Wisconsin
Breast Cancer (5)Prostate Cancer (4)Colorectal Cancer (3)Solid Tumor (3)Acute Myeloid Leukemia (3)Anxiety (3)Heart Failure (3)Mantle Cell Lymphoma (MCL) (3)Healthy (2)Metastatic Castration-resistant Prostate Cancer (2)Pancreatic Ductal Adenocarcinoma (2)Relapsing Remitting Multiple Sclerosis (2)

Frequently Asked Questions — Clinical Trials in Wisconsin

How many clinical trials are currently recruiting in Wisconsin?
ClinicalMetric currently tracks 167 actively recruiting clinical trials with at least one location in Wisconsin. The total number of registered studies—including active but not currently enrolling trials—is 167. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Wisconsin?
Wisconsin hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Prostate Cancer, Colorectal Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Wisconsin serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Wisconsin?
To join a clinical trial in Wisconsin, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Wisconsin maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Wisconsin

NCT06848946 Phase 4
Recruiting
Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alon...
Condition
Glaucoma, Open-angle
Enrollment
132 pts
Location
United States
Sponsor
Glaukos Corporation
View Trial →
NCT05923203 N/A
Recruiting
Combined Electric and Acoustic Hearing (EAS) in Children and Adults
Condition
Cochlear Implant
Enrollment
160 pts
Location
United States
Sponsor
Hearts for Hearing
View Trial →
NCT07125209 N/A
Recruiting
Cognitive Impact of Neoadjuvant Chemotherapy for Gynecologic Cancers
Condition
Ovarian Cancer
Enrollment
18 pts
Location
United States
Sponsor
University of Wisconsin, Madis
View Trial →
NCT04771130 Phase 1, Phase 2
Recruiting
A Study of BGB-11417 in Participants With Myeloid Malignancies
Condition
Acute Myeloid Leukemia
Enrollment
260 pts
Location
United States, Australia, China
Sponsor
BeOne Medicines
View Trial →
NCT05887609 Phase 2
Recruiting
An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and O...
Condition
Ovary Cancer
Enrollment
53 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT06679634 Phase 2
Recruiting
Retinoblastoma Phase II Expanded Access Clinical Trial
Condition
Retinoblastoma
Enrollment
30 pts
Location
United States
Sponsor
Targeted Therapy Technologies,
View Trial →
NCT05472909 N/A
Recruiting
Music Interventions During Wide-Awake Hand Surgery
Condition
Anxiety
Enrollment
170 pts
Location
United States
Sponsor
University of Wisconsin, Madis
View Trial →
NCT06736574 Phase 3
Recruiting
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With S...
Condition
Heart Failure
Enrollment
1,800 pts
Location
United States, Canada, China
Sponsor
Cytokinetics
View Trial →
NCT04785989 N/A
Recruiting
In Vivo Metabolic Profiling of CLL (Chronic Lymphocytic Leukemia)
Condition
Chronic Lymphocytic Leukemia
Enrollment
16 pts
Location
United States
Sponsor
University of Wisconsin, Madis
View Trial →
NCT03266640 Phase 2
Recruiting
Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CM...
Condition
Cytomegalovirus Infections
Enrollment
20 pts
Location
United States
Sponsor
New York Medical College
View Trial →
NCT05826860 N/A
Recruiting
Storytelling and Mindfulness for Graduate Student Wellbeing
Condition
Depression
Enrollment
250 pts
Location
United States
Sponsor
University of Wisconsin, Madis
View Trial →
NCT07086976 Phase 3
Recruiting
A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzab...
Condition
Autoimmune Haemolytic Anaemia
Enrollment
90 pts
Location
United States, Argentina, Austria
Sponsor
Sanofi
View Trial →
NCT05701917 N/A
Recruiting
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombos...
Condition
Venous Thromboembolism
Enrollment
300 pts
Location
United States, Austria, Finland
Sponsor
Inari Medical
View Trial →
NCT07118358 N/A
Recruiting
BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System
Condition
Leadless Pacemaker
Enrollment
325 pts
Location
United States, Australia, Austria
Sponsor
Biotronik, Inc.
View Trial →
NCT07629440 Phase 3
Recruiting
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
Condition
Pneumococcal Disease
Enrollment
3,230 pts
Location
United States, Japan, Puerto Rico
Sponsor
Pfizer
View Trial →
NCT06222580 Phase 1
Recruiting
SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Muta...
Condition
Acute Myeloid Leukemia With FLT3/ITD Mutation
Enrollment
30 pts
Location
United States
Sponsor
Uma Borate
View Trial →
NCT05222620 Phase 2
Recruiting
SRS Compared With FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIO...
Condition
Metastatic Malignant Neoplasm in the Brain
Enrollment
90 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →
NCT06595459 Phase 4
Recruiting
The Options 2 Study
Condition
Smoker
Enrollment
300 pts
Location
United States
Sponsor
University of Wisconsin, Madis
View Trial →
NCT06312176 Phase 3
Recruiting
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combinatio...
Condition
Breast Neoplasms
Enrollment
1,200 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT07392255 Phase 1, Phase 2
Recruiting
An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx00...
Condition
Geographic Atrophy Secondary to Age-related Macular Degeneration
Enrollment
75 pts
Location
United States, United Kingdom
Sponsor
Complement Therapeutics
View Trial →
NCT06788652 N/A
Recruiting
A Study of Patients With Relapsed/Refractory Mantle Cell Lymphoma Treated With L...
Condition
Mantle Cell Lymphoma (MCL)
Enrollment
300 pts
Location
United States
Sponsor
Juno Therapeutics, Inc., a Bri
View Trial →
NCT06159335 Phase 3
Recruiting
18F-FLUC PET/MR in Patients With Brain Mets
Condition
Brain Metastasis
Enrollment
30 pts
Location
United States
Sponsor
University of Wisconsin, Madis
View Trial →
NCT06747117 N/A
Recruiting
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus ...
Condition
Lower Extremity Acute Limb Ischemia
Enrollment
300 pts
Location
United States, Australia, Brazil
Sponsor
Penumbra Inc.
View Trial →
NCT02688517 N/A
Recruiting
Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
Condition
Malignant Neoplasm
Enrollment
1,100 pts
Location
United States
Sponsor
Rutgers, The State University
View Trial →
NCT06940440 Phase 1
Recruiting
IFx-Hu2.0 As An Adjunctive Therapy To Pembrolizumab In Advanced Or Metastatic Me...
Condition
Advanced Or Metastatic Merkel Cell Carcinoma
Enrollment
9 pts
Location
United States
Sponsor
TuHURA Biosciences, Inc.
View Trial →
Page 2 of 7 — 167 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology